These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 16204008

  • 1. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D, Fong L.
    J Clin Oncol; 2005 Dec 10; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract] [Full Text] [Related]

  • 2. Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206.
    Ribas A, Camacho LH, Lopez-Berestein G, Pavlov D, Bulanhagui CA, Millham R, Comin-Anduix B, Reuben JM, Seja E, Parker CA, Sharma A, Glaspy JA, Gomez-Navarro J.
    J Clin Oncol; 2005 Dec 10; 23(35):8968-77. PubMed ID: 16204013
    [Abstract] [Full Text] [Related]

  • 3. Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma.
    Phan GQ, Yang JC, Sherry RM, Hwu P, Topalian SL, Schwartzentruber DJ, Restifo NP, Haworth LR, Seipp CA, Freezer LJ, Morton KE, Mavroukakis SA, Duray PH, Steinberg SM, Allison JP, Davis TA, Rosenberg SA.
    Proc Natl Acad Sci U S A; 2003 Jul 08; 100(14):8372-7. PubMed ID: 12826605
    [Abstract] [Full Text] [Related]

  • 4. Anticytotoxic T lymphocyte-associated antigen 4 treatment--can melanoma be cured at the expense of autoimmune disorders?
    Lejeune FJ.
    Melanoma Res; 2006 Oct 08; 16(5):377-8. PubMed ID: 17013085
    [No Abstract] [Full Text] [Related]

  • 5. CTLA-4 blockade: unveiling immune regulation.
    Dranoff G.
    J Clin Oncol; 2005 Feb 01; 23(4):662-4. PubMed ID: 15613692
    [No Abstract] [Full Text] [Related]

  • 6. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS, Quezada SA, Korman AJ, Allison JP.
    Curr Opin Immunol; 2006 Apr 01; 18(2):206-13. PubMed ID: 16464564
    [Abstract] [Full Text] [Related]

  • 7. Future directions in tumor immunotherapy: CTLA4 blockade.
    Gulley JL, Dahut WL.
    Nat Clin Pract Oncol; 2007 Mar 01; 4(3):136-7. PubMed ID: 17327854
    [No Abstract] [Full Text] [Related]

  • 8. Overcoming immunological tolerance to melanoma: Targeting CTLA-4.
    Hodi FS.
    Asia Pac J Clin Oncol; 2010 Mar 01; 6 Suppl 1():S16-23. PubMed ID: 20482528
    [Abstract] [Full Text] [Related]

  • 9. Synergistic antitumor effect of chemotactic-prostate tumor-associated antigen gene-modified tumor cell vaccine and anti-CTLA-4 mAb in murine tumor model.
    Li N, Qin H, Li X, Zhou C, Wang D, Ma W, Lin C, Zhang Y, Wang S, Zhang S.
    Immunol Lett; 2007 Nov 15; 113(2):90-8. PubMed ID: 17913245
    [Abstract] [Full Text] [Related]

  • 10. Strategies for immunotherapy of cancer.
    Melief CJ, Toes RE, Medema JP, van der Burg SH, Ossendorp F, Offringa R.
    Adv Immunol; 2000 Nov 15; 75():235-82. PubMed ID: 10879286
    [No Abstract] [Full Text] [Related]

  • 11. Biologic and immunomodulatory events after CTLA-4 blockade with ticilimumab in patients with advanced malignant melanoma.
    Reuben JM, Lee BN, Li C, Gomez-Navarro J, Bozon VA, Parker CA, Hernandez IM, Gutierrez C, Lopez-Berestein G, Camacho LH.
    Cancer; 2006 Jun 01; 106(11):2437-44. PubMed ID: 16615096
    [Abstract] [Full Text] [Related]

  • 12. Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy.
    Engelhard VH, Bullock TN, Colella TA, Sheasley SL, Mullins DW.
    Immunol Rev; 2002 Oct 01; 188():136-46. PubMed ID: 12445287
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.